Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae
- PMID: 29866876
- PMCID: PMC6105851
- DOI: 10.1128/AAC.00236-18
Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae
Abstract
The next-generation aminoglycoside plazomicin, in development for infections due to multidrug-resistant (MDR) Enterobacteriaceae, was evaluated alongside comparators for bactericidal activity in minimum bactericidal concentration (MBC) and time-kill (TK) assays against MDR Enterobacteriaceae isolates with characterized aminoglycoside and β-lactam resistance mechanisms. Overall, plazomicin and colistin were the most potent, with plazomicin demonstrating an MBC50/90 of 0.5/4 μg/ml and sustained 3-log10 kill against MDR Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp.
Keywords: Enterobacteriaceae; bactericidal; bactericidal activity; multidrug resistance; plazomicin.
Copyright © 2018 Thwaites et al.
Figures
References
-
- Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM. 2009. Complete nucleotide sequences of plasmids pEK204, pEK499 and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international 025:H4-ST131 clone. Antimicrob Agents Chemother 53:4472–4482. doi:10.1128/AAC.00688-09. - DOI - PMC - PubMed
-
- Centers for Disease Control and Prevention. 2013. Biggest threats. Centers for Disease Control and Prevention, Atlanta, GA: https://www.cdc.gov/drugresistance/biggest_threats.html.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
